Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Distribution of ADAMTS13 Inhibitor Levels as a Function of ADAMTS13 Activity

ADLM 2025

Association for Diagnostics and Laboratory medicine

Chicago, IL, July 27-31 , 2025

Poster presentation: Distribution of ADAMTS13 Inhibitor Levels as a Function of ADAMTS13 Activity

Authors: Wong E

Medical Specialty: Hematology, Coagulation, Oncology, Immunology

Related content

Test FAQ
ADAMTS13 Activity with Reflex to ADAMTS13 Inhibitor
Conference Presentation
The First Report of the American Society for Apheresis Thrombotic Thrombocytopenic Purpura Multi-institutional Registry: 2019-2020
Conference Presentation
Inadvertent rare use of plasma exchange in the treatment of Upshaw-Shulman syndrome
Conference Presentation
Using GP1bM Activity (VWF:GPIbM) Versus Ristocetin Cofactor Activity (VWF:RCo) in von Willebrand Factor Panels
Test FAQ
Lupus Anticoagulant (LA) Evaluation with Reflex

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.